openPR Logo
Press release

Post Traumatic Stress Disorder (PTSD) Therapeutics Market to Remain Lucrative During 2019

12-28-2017 11:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Post Traumatic Stress Disorder (PTSD) Therapeutics Market

Post-traumatic stress disorder (PTSD) is a psychological condition that occurs in individuals of any age and gender. Its symptoms can show up immediately after a traumatic experience or with the course of time. It is one of the most common psychological disorders, affecting about 8 mn adult Americans and an annual incidence rate of close to 3.5% across the globe. Its first line of treatments includes counseling and psychotherapy. The population at risk includes veterans and soldiers. Some of the drugs that are usually prescribed are Zoloft by Pfizer, Elavil by AstraZeneca, and Paxil by GlaxoSmithKline.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/post-traumatic-stress-disorder.html

The research report provides an in-depth analysis of the dynamics of the global PTSD therapeutics market and the extent to which they impact the growth of the market. It offers insights into the historical data and current scenario of the market to understand the growth rate of the market and also to make predictions about the future trends. For a coherent understanding, it segments the market on the basis of various criteria including treatment and geography. It presents invaluable information regarding the different parameters of the market that help new as well as existing players in making informed business decisions. It extensively covers the competitive landscape of the global PTSD therapeutics market.

The rising prevalence of PTSD is the primary factor driving the global PTSD therapeutics market. Globally, there are increasing cases of cross-border tensions and violence. To control such situations, military troops and police forces are deployed at sights of violence. This is leading to the development of PTSD among military personnel, which in turn is driving the demand for therapeutics for the treatment of this disorder. In addition, the increasing emphasis on rehabilitation programs for injured military personnel is working in favor of the growth of the market. Moreover, the growing number of road accidents, particularly in developing countries, is augmenting the market.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1950

On the flip side, the serious side effects of certain drugs are leading to bad publicity and several lawsuits, which in turn is adversely affecting the growth of the market. Consumption of Zoloft and Paxil by pregnant women led to septal heart defects, miscarriage, delayed development, cranial defect, and persistent pulmonary hypertension (PPHN). However, the increasing research and development activities for understanding the mechanisms underlying PTSD is likely to pave way for new and safe therapeutics.

The key segments studied in the report on the basis of geography are Asia Pacific, Europe, North America, and Rest of the World. North America will be one of the major revenue contributors to the growth of the global market. The rising prevalence of PTSD is fuelling the demand for its therapeutics in the region. The presence of pharmaceutical giants along with the increasing research and development in the field is providing a fillip to the growth of the region. Asia Pacific will be a potential market owing to the high rate of motor accidents in high population countries.

The global PTSD therapeutics market is characterized by high competitive rivalry. The market scenario is anticipated to change after the launch of novel therapies. Some of the prominent players in the market are GlaxoSmithKline, Pfizer, Neurocrine Biosciences, Novartis Pharmaceuticals, Azevan Pharmaceuticals, and Baylor Research Institute.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1950<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Post Traumatic Stress Disorder (PTSD) Therapeutics Market to Remain Lucrative During 2019 here

News-ID: 878437 • Views: 124

More Releases from Transparency Market Research

Dielectric Gases Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Dielectric Gases Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Dielectric Gases market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Dielectric Gases market over the
Oxalic Acid Market Size will Observe Lucrative Surge by the End 2027
Overview TMR’s report on the Oxalic Acid Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Oxalic Acid market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Oxalic Acid market over the
Long Fiber Thermoplastics Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Long Fiber Thermoplastics Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Long Fiber Thermoplastics market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Long Fiber Thermoplastics
High Performance Foaming Agents Market Size will Observe Lucrative Surge by the …
Overview TMR’s report on the High Performance Foaming Agents Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the High Performance Foaming Agents market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the High

All 5 Releases


More Releases for PTSD

Post-Traumatic Stress Disorder (PTSD) Therapeutics Pipeline Analysis Report
The study analysed that the PTSD pipeline comprises of 23 drug candidates in different stages of development. PTSD is a neurological disorder that develops in people who have experienced a scary or a dangerous event. PTSD can occur in a person at any age. According to the National Center of PTSD, around seven to eight out of 100 individuals experience PTSD at some point in their lives. Most of the
Worldwide Analysis on Post-Traumatic Stress Disorder (PTSD) Therapeutics Market …
Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market: Overview Post-traumatic stress disorder (PTSD) is a psychological condition that occurs in individuals of any age and gender. Its symptoms can show up immediately after a traumatic experience or with the course of time. It is one of the most common psychological disorders, affecting about 8 mn adult Americans and an annual incidence rate of close to 3.5% across the globe. Its first line
Post-Traumatic Stress Disorder (PTSD) - Pipeline Insight and Therapeutic Assessm …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Post-Traumatic Stress Disorder (PTSD)-Pipeline Insight, 2017” to its report offerings. The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265521 The report provides comprehensive insights of the ongoing therapeutic research and development across Post-Traumatic Stress Disorder (PTSD). The report provides a complete understanding of the
PTSD Exhibits Emerging Pipeline with 23 Drug Candidates
The study analysed that the PTSD pipeline comprises of 23 drug candidates, of which one drug candidate is in the Phase III stage of development, two drug candidates are in the Phase II stage of development, seven drug candidates are in the Pre-Clinical stage of development, two drug candidates are in Discovery stage, one drug candidate is in Unknown Clinical stage, one drug candidate is in the Discontinued stage and
Donald Trump And PTSD: PTSD Is Not A Sign Of Weakness Says June Sitler, Author O …
PTSD can take many forms. When one hears Post Traumatic Stress Disorder (PTSD) the image of a Vietnam Vet comes to mind. However, many people from all walks of life may suffer from this disorder. They are the survivors. They can be people who live in the inner city, those who have suffered the loss of a loved one, survivors of childhood trauma in adulthood, or a man or woman
Heal My PTSD Launches Virtual PTSD Support Groups
FOR IMMEDIATE RELEASE Contact: Michele Rosenthal Michele@healmyptsd.com 561.531.1405 Heal My PTSD Launches Virtual PTSD Support Groups January 17, 2011 – Self-Empowered Healing Coach, Michele Rosenthal, founder of www.healmyptsd.com, will launch virtual PTSD support groups for both survivors and caregivers on February 7, 2011. Conducted via a telephone conference line, these groups will be the first of their kind to provide a live support forum for survivors and